Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.620
+0.020 (1.25%)
At close: Dec 31, 2025, 4:00 PM EST
1.590
-0.030 (-1.85%)
After-hours: Dec 31, 2025, 7:11 PM EST
Metagenomi Stock Forecast
MGX's stock price has decreased by -53.98% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 4 analysts that cover Metagenomi stock have a consensus rating of "Strong Buy" and an average price target of $9.25, which forecasts a 470.99% increase in the stock price over the next year. The lowest target is $7.00 and the highest is $12.
Price Target: $9.25 (+470.99%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 19, 2025.
Analyst Ratings
The average analyst rating for Metagenomi stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7 | Strong Buy | Reiterates | $7 | +332.10% | Aug 19, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $12 → $11 | Strong Buy | Maintains | $12 → $11 | +579.01% | Aug 15, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $16 → $12 | Buy | Maintains | $16 → $12 | +640.74% | Aug 14, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $13 → $12 | Strong Buy | Maintains | $13 → $12 | +640.74% | May 15, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $20 → $16 | Buy | Maintains | $20 → $16 | +887.65% | May 14, 2025 |
Financial Forecast
Revenue This Year
28.25M
from 52.30M
Decreased by -45.98%
Revenue Next Year
22.21M
from 28.25M
Decreased by -21.36%
EPS This Year
-2.38
from -2.36
EPS Next Year
-1.84
from -2.38
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 31.5M | 36.8M | ||||
| Avg | 28.2M | 22.2M | ||||
| Low | 25.6M | 15.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -39.8% | 30.1% | ||||
| Avg | -46.0% | -21.4% | ||||
| Low | -51.1% | -43.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -2.33 | -1.42 | ||||
| Avg | -2.38 | -1.84 | ||||
| Low | -2.49 | -2.58 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.